Evidence map›Paper›PMID 37920391›Full record

ArticleRSC chemical biology2023

Thinking outside the CaaX-box: an unusual reversible prenylation on ALDH9A1.

Kiall F Suazo, Jakub Bělíček, Garrett L Schey, Shelby A Auger, Alexandru M Petre, Ling Li, Katarzyna M Błażewska, David Kopečný, Mark D Distefano

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. ACS chemical biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Kiall F SuazoDepartment of Chemistry, University of Minnesota Minneapolis MN 55455 USA suazo003@umn.edu auger054@umn.edu petre096@umn.edu diste001@umn.edu.ORCID https://orcid.org/0000-0002-0803-8332
Jakub BělíčekDepartment of Experimental Biology, Faculty of Science, Palacký University CZ-78371 Czech Republic jakub.belicek01@upol.cz david.kopecny@upol.cz.ORCID https://orcid.org/0000-0002-9538-7054
Garrett L ScheyDepartment of Medicinal Chemistry, University of Minnesota Minneapolis MN 55455 USA schey013@umn.edu.ORCID https://orcid.org/0000-0001-9049-3133
Shelby A AugerDepartment of Chemistry, University of Minnesota Minneapolis MN 55455 USA suazo003@umn.edu auger054@umn.edu petre096@umn.edu diste001@umn.edu.ORCID https://orcid.org/0000-0003-2873-2580
Alexandru M PetreDepartment of Chemistry, University of Minnesota Minneapolis MN 55455 USA suazo003@umn.edu auger054@umn.edu petre096@umn.edu diste001@umn.edu.ORCID https://orcid.org/0000-0003-2818-6073
Ling LiDepartment of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis MN 55455 USA lil@umn.edu.ORCID https://orcid.org/0000-0002-9245-7387
Katarzyna M BłażewskaInstitute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology Łódź Poland katarzyna.blazewska@p.lodz.pl.ORCID https://orcid.org/0000-0002-1218-7111
David KopečnýDepartment of Experimental Biology, Faculty of Science, Palacký University CZ-78371 Czech Republic jakub.belicek01@upol.cz david.kopecny@upol.cz.ORCID https://orcid.org/0000-0002-4309-4284
Mark D DistefanoDepartment of Chemistry, University of Minnesota Minneapolis MN 55455 USA suazo003@umn.edu auger054@umn.edu petre096@umn.edu diste001@umn.edu.ORCID https://orcid.org/0000-0002-2872-0259
University of Minnesota · USPalacký University Olomouc · CZLodz University of Technology · PL

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
TRAINING FOR FUTURE BIOTECHNOLOGY DEVELOPMENTT32GM008347 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SCHMIDT-DANNERT, CLAUDIA · 1990 to 2021
$11.0M
Training Grant: Functional Proteomics of AgingT32AG029796 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, Douglas G Mashek · 2008 to 2026
$6.6M
Training the Next Generation of Chemical BiologistsT32GM132029 · NIGMS · UNIVERSITY OF MINNESOTA · PI Erin Elizabeth Carlson, William Charles Krause Pomerantz · 2019 to 2026
$2.7M
Chemical Approaches for Exploring Protein Prenylation in Living CellsR35GM141853 · NIGMS · UNIVERSITY OF MINNESOTA · PI MARK D DISTEFANO · 2021 to 2026
$2.4M
Dysregulation of Protein Prenylation in the Pathogenesis of Alzheimer's DiseaseRF1AG056976 · NIA · UNIVERSITY OF MINNESOTA · PI DISTEFANO, MARK D, LI, LING · 2017 to 2017
$1.9M
NCI NIH HHS P30 CA077598NIA NIH HHS RF1 AG056976NIA NIH HHS T32 AG029796NIGMS NIH HHS R35 GM141853NIGMS NIH HHS T32 GM008347NIGMS NIH HHS T32 GM132029
6 · The paper itself

Abstract

Protein lipidation is a post-translational modification that confers hydrophobicity on protein substrates to control their cellular localization, mediate protein trafficking, and regulate protein function. In particular, protein prenylation is a C-terminal modification on proteins bearing canonical motifs catalyzed by prenyltransferases. Prenylated proteins have been of interest due to their numerous associations with various diseases. Chemical proteomic approaches have been pursued over the last decade to define prenylated proteomes (prenylome) and probe their responses to perturbations in various cellular systems. Here, we describe the discovery of prenylation of a non-canonical prenylated protein, ALDH9A1, which lacks any apparent prenylation motif. This enzyme was initially identified through chemical proteomic profiling of prenylomes in various cell lines. Metabolic labeling with an isoprenoid probe using overexpressed ALDH9A1 revealed that this enzyme can be prenylated inside cells but does not respond to inhibition by prenyltransferase inhibitors. Site-directed mutagenesis of the key residues involved in ALDH9A1 activity indicates that the catalytic C288 bears the isoprenoid modification likely through an NAD

Identifiers

PMID37920391
PMCPMC10619140
OpenAlexW4386264813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.